Be used to strengthen to use therapeutic combination at the effect of the therapy of the antibody of EGF-R ELISA

Be used to strengthen to use therapeutic combination at the effect of the therapy of the antibody of EGF-R ELISA

  • CN 101,678,099 A
  • Filed: 09/27/2007
  • Published: 03/24/2010
  • Est. Priority Date: 09/29/2006
  • Status: Active Application
First Claim
Patent Images

1. be used for the treatment of the treatment for cancer compositions, it is characterized in that, when comprising or use in turn at the monoclonal antibody of EGF receptor and one or more I type interferon.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×